Venice, FL (PRWEB) February 28, 2009
SinoFresh Healthcare Inc. ("the Company") (OTCBB: SFSH.OB) announced that the Company voluntarily filed a Form 15 with the Securities and Exchange Commission ("SEC") on February 18, 2009, thereby, voluntarily suspending its reporting obligations under the Securities Exchange Act of 1934.
As a result of filing the Form 15, the Company will no longer be required to file annual and quarterly reports with the SEC. The Company took this action in order to focus its resources on further developing and marketing its unique antiseptic nasal and sinus care product.
The Company's common stock will continue to be eligible for public trading, only now it will occur through the Pink Sheets ( http://www.pinksheets.com ) quotations system instead of the OTC Bulletin Board. The change in trading venue is to become effective within 90 days of filing with the SEC; however, SinoFresh Healthcare Inc. will suspend all periodic report filing with the SEC, effective immediately.
"An overwhelming amount of resources have been expended over the past several years for auditing, filing and legal expenses in the desire to maintain an OTC Bulletin Board listing," stated Charles Fust, CEO of Sinofresh Healthcare Inc. "Focusing our limited resources on reducing our debt load and establishing strategic relationships to market our Sinofresh Nasal Spray product best serves the interests of our shareholders. The Company takes this step after carefully considering the advantages and disadvantages of continuing registration reporting. The costs and administrative burdens associated with being a public company have significantly increased, particularly in light of the Sarbanes-Oxley requirements make current on-going reporting financially infeasible.
The Company plans to provide timely quarterly and annual reports pertaining to its financial performance and other announcements on its website and through the Pink Sheets Disclosure and News Service.
About SinoFresh HealthCare, Inc.
SinoFresh HealthCare, Inc. is dedicated to research efforts and products designed to eliminate causal agents in the area of upper respiratory health and the potential positive impact upon the reduction of mold, fungus, viral and bacterial pathogens using patented, innovative preventative measures. The company's lead product, SinoFresh(TM) Nasal and Sinus Care is a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants is available nationwide.
This press release contains forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "targets," "projects," "believes," "seeks," "estimates" and similar expressions are intended to identify such forward-looking statements. These statements are based on the current expectations or beliefs of Sinofresh Healthcare Inc. management. They are not guarantees of future performance and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Unless legally required, we undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
Contacts: Sinofresh Healthcare Inc. 941-484-2929